QELBREE 150 mg/1

QELBREE 150 mg is an extended-release capsule containing viloxazine hydrochloride, used for managing certain mental health conditions. This medication is designed to provide sustained relief and is manufactured by Supernus Pharmaceuticals, Inc.

QELBREE 150 mg is primarily used to address symptoms associated with attention deficit hyperactivity disorder (ADHD). It works by modulating certain neurotransmitters in the brain, which can help improve focus and reduce impulsivity. People often wonder, 'What is QELBREE used for?' and the answer lies in its ability to support mental health by managing ADHD symptoms.

Common effects of QELBREE 150 mg may include changes in appetite, sleep patterns, and mood. Some users report feeling more alert and focused, while others may experience mild gastrointestinal discomfort. These effects can vary from person to person and typically subside as the body adjusts to the medication.

QELBREE 150 mg should be handled with care, especially for those with a history of heart conditions or high blood pressure. It is important to follow the prescribed guidelines and consult a healthcare provider before starting or stopping the medication. Always store the capsules in a cool, dry place away from direct sunlight.

QELBREE 150 mg may interact with certain medications, including those that affect liver enzymes or other mental health treatments. Alcohol and other central nervous system depressants should be avoided while taking this medication. Always inform your healthcare provider about all the medications you are currently taking to avoid potential interactions.